EZOLVIN Tablets and Syrup

Name of the Product

EZOLVIN Tablets
EZOLVIN Syrup

Composition

Each EZOLVIN tablet contains: Bromhexine HCl 8 mg.
Each 5 ml of EZOLVIN syrup contains: Bromhexine HCl 4 mg.

Presentation

EZOLVIN tablets are available in blister packs of 20 tablets.
EZOLVIN syrup is available in glass bottles of 60 ml and 100 ml.

Indications

EZOLVIN is a mucolytic used in the treatment of acute and chronic respiratory diseases associated with productive cough, where there is abnormal mucus secretion or transport. It is suitable to be taken with antibiotics in cases of respiratory infections.

EZOLVIN works by reducing the viscosity of the mucus, increasing its mass, and activating the epithelial ciliated cells, leading to facilitate expectoration by coughing in cases such as:

• Bronchial Asthma
• Bronchitis with Bronchospasm
• Emphysema
• Acute and Chronic Pneumonia

Dosage and Administration

• Children < 2 years: 1/4 teaspoonful (1.25 ml) of EZOLVIN syrup three times daily.
• Children 2-5 years: 1/2 EZOLVIN tablet, twice daily, or 1/2 teaspoonful (2.5 ml) of EZOLVIN syrup three times daily.
• Children 5-10 years: 1/2 EZOLVIN tablet, or 1 teaspoonful (5 ml) of EZOLVIN syrup three times daily.
• Adults and children >10 years: 1 EZOLVIN tablet, or 2 teaspoonfuls (10 ml) of EZOLVIN syrup three times daily.

Precautions

EZOLVIN should be taken with caution in patients with a history of peptic ulcer and severe hepatic or renal impairment. Care should be taken if EZOLVIN is given to lactating or pregnant women, especially in the first trimester.

Contraindications

EZOLVIN should not be used for patients suffering from hypersensitivity to Bromhexine or who have acute peptic ulcer.

Drug Interactions

Concurrent use of Bromhexine with antibiotics increases their penetration into lung tissues and bronchial secretions.

Pharmacokinetics

EZOLVIN is rapidly absorbed after oral administration, with peak plasma concentration occurring in one hour. It is excreted mainly in the urine.

Overdosage

No symptoms of overdosage have been reported; however, if they occur, symptomatic treatment is required.

Storage Conditions

Store below 25°C, protect from light.

---

Important Notes:

• A medicine is a product that affects your health, and its consumption contrary to instructions is harmful to you.
• Follow strictly the doctor’s prescription, the method of use, and instructions of the pharmacist who dispensed the medicine.
• The doctor and the pharmacist are experts in medicine, its benefits, and harms.
• Do not stop taking this medication unless advised by your doctor.
• Do not repeat the same prescription without consulting your doctor.
• Keep medicine out of reach of children.

---

Council of Arab Health Ministers – Union of Arab Pharmacists

Kuwait Saudi Pharmaceutical Industries Co.

Review Date: MARCH/2008

Contact Information:
P.O. Box: 5512 Safat – Postal Code: 13056 State of Kuwait – Subhan Industrial Area
Tel: 965 24745012/3/4 | Fax: 965 24745361
www.kspico.com